DE50305587D1 - 2-heteroarylcarbonsäureamide - Google Patents

2-heteroarylcarbonsäureamide

Info

Publication number
DE50305587D1
DE50305587D1 DE50305587T DE50305587T DE50305587D1 DE 50305587 D1 DE50305587 D1 DE 50305587D1 DE 50305587 T DE50305587 T DE 50305587T DE 50305587 T DE50305587 T DE 50305587T DE 50305587 D1 DE50305587 D1 DE 50305587D1
Authority
DE
Germany
Prior art keywords
heteroarylcarbonsäureamide
prophylaxis
learning
diseases
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50305587T
Other languages
German (de)
English (en)
Inventor
Joachim Luithle
Frank-Gerhard Boess
Christina Erb
Frank-Thorsten Hafner
Katrin Schnizler
Timo Flessner
Kampen Marja Van
Der Staay Franz-Josef Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to DE50305587T priority Critical patent/DE50305587D1/de
Application granted granted Critical
Publication of DE50305587D1 publication Critical patent/DE50305587D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE50305587T 2002-06-10 2003-06-02 2-heteroarylcarbonsäureamide Expired - Lifetime DE50305587D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50305587T DE50305587D1 (en) 2002-06-10 2003-06-02 2-heteroarylcarbonsäureamide

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide
DE50305587T DE50305587D1 (en) 2002-06-10 2003-06-02 2-heteroarylcarbonsäureamide
PCT/EP2003/005735 WO2003104227A1 (de) 2002-01-20 2003-06-02 2-heteroarylcarbonsäureamide

Publications (1)

Publication Number Publication Date
DE50305587D1 true DE50305587D1 (en) 2006-12-14

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
DE50305587T Expired - Lifetime DE50305587D1 (en) 2002-06-10 2003-06-02 2-heteroarylcarbonsäureamide

Country Status (16)

Country Link
US (5) US7977485B2 (enExample)
EP (1) EP1515967B1 (enExample)
JP (1) JP4542891B2 (enExample)
CN (1) CN1675204A (enExample)
AT (1) ATE344262T1 (enExample)
AU (1) AU2003238450A1 (enExample)
BR (1) BR0312446A (enExample)
CA (1) CA2488761C (enExample)
DE (1) DE50305587D1 (enExample)
ES (1) ES2276072T3 (enExample)
IL (1) IL165505A0 (enExample)
MX (1) MXPA04012439A (enExample)
NO (1) NO20050063L (enExample)
PL (1) PL374551A1 (enExample)
UY (1) UY27841A1 (enExample)
WO (1) WO2003104227A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ES2276072T3 (es) * 2002-06-10 2007-06-16 Bayer Healthcare Ag Amidas de acidos 2-heteroarilcarboxilicos.
CA2499128C (en) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
WO2005016923A1 (en) 2003-08-13 2005-02-24 Neurosearch A/S Novel quinuclidine derivatives and their pharmaceutical use
PL1697378T3 (pl) 2003-12-22 2008-04-30 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
WO2005092890A2 (en) 2004-03-25 2005-10-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
US7514450B2 (en) 2004-05-19 2009-04-07 Neurosearch A/S Azabicyclic aryl derivatives
CA2584836A1 (en) 2004-10-15 2006-04-20 Neurosearch A/S Novel azabicyclic aryl derivatives and their medical use
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
WO2009081970A1 (ja) * 2007-12-26 2009-07-02 Eisai R & D Management Co., Ltd. ヘテロ環置換ピリジン誘導体の製造方法
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體
CA2821480A1 (en) 2010-12-20 2012-06-28 Astrazeneca Ab 2-carboxamide-4-piperazinyl-benzofuran derivative
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法
EP4213832A4 (en) * 2020-09-18 2024-10-16 Merck Sharp & Dohme LLC Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
CZ2004408A3 (cs) * 2001-10-02 2005-03-16 Pharmacia & Upjohn Company Azabicyklicky substituované kondenzované heteroarylsloučeniny
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ES2276072T3 (es) * 2002-06-10 2007-06-16 Bayer Healthcare Ag Amidas de acidos 2-heteroarilcarboxilicos.
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Also Published As

Publication number Publication date
AU2003238450A1 (en) 2003-12-22
NO20050063L (no) 2005-01-06
US20160122337A1 (en) 2016-05-05
US20140350008A1 (en) 2014-11-27
MXPA04012439A (es) 2005-04-19
UY27841A1 (es) 2003-12-31
CA2488761A1 (en) 2003-12-18
CA2488761C (en) 2011-05-31
CN1675204A (zh) 2005-09-28
EP1515967B1 (de) 2006-11-02
JP4542891B2 (ja) 2010-09-15
US10214524B2 (en) 2019-02-26
PL374551A1 (en) 2005-10-31
WO2003104227A1 (de) 2003-12-18
US20110263591A1 (en) 2011-10-27
US9067931B2 (en) 2015-06-30
US7977485B2 (en) 2011-07-12
US20060160877A1 (en) 2006-07-20
IL165505A0 (en) 2006-01-15
ES2276072T3 (es) 2007-06-16
ATE344262T1 (de) 2006-11-15
BR0312446A (pt) 2005-04-19
JP2005533052A (ja) 2005-11-04
US20120258964A1 (en) 2012-10-11
EP1515967A1 (de) 2005-03-23

Similar Documents

Publication Publication Date Title
IL165505A0 (en) 2-heteroaryl carboxamides
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
NL300933I2 (nl) Letermovir
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
DE50310516D1 (de) Fredericamycin-derivate
WO2005063734A3 (de) Substituierte thiophene
ATE453642T1 (de) Substituierte phenylaminopyrimidine
MA28613B1 (fr) Macrocycles d'amide antibacteriens
WO2003078430A8 (de) Essig- und propionsäureamide
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
TW200510449A (en) Acylated nonadepsipeptides
NO20055741L (no) Nye kjemiske forbindelser
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
TW200621799A (en) Acylated nonadepsipeptides II
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
WO2004048321A8 (de) Phenylsulfoxid- und -sulfon-derivate
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
ATE455789T1 (de) Substituierte nonadepsipeptide
TW200508237A (en) 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
MXPA03006742A (es) Uso de buprenorfina para la terapia de la incontinencia urinaria.
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE